Cardiovascular Disease in Men with Prostate Cancer Videos

Meta-Analysis Evaluates Cardiovascular Risks of AR Inhibitors in Prostate Cancer - Omar El-Taji & Ashwin Sachdeva

June 28, 2024

Details

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers on the Cardiovascular System Effects and Modifications - Alicia Morgans

June 22, 2021

Details

Assessment and Treatment of Cardiovascular Risk Factors in Veterans with Prostate Cancer - Ravi Parikh and Lova Sun

May 12, 2021

Details

The Cardiovascular Complications of Therapy for Patients with Prostate Cancer - Vivek Narayan

April 9, 2021

Details

Cardiovascular Adverse Events and Comorbidity Considerations Disease in Men with Non-Metastatic Prostate Cancer - Christopher Wallis & Zachary Klaassen

March 16, 2021

Details

Increased Risk for CV Disease in Men with Prostate Cancer - Alicia Morgans and Oliver Sartor

March 15, 2021

Details

Lower Odds of Cardiac Events for Gonadotropin Releasing Hormone Antagonists versus Agonists - Eugene Cone

August 29, 2020

Details

The Oral GnRH Receptor Antagonist Relugolix as Neoadjuvant/Adjuvant ADT to EBRT in Patients with Intermediate-risk Prostate Cancer - Thomas Keane

August 24, 2020

Details

The Intersection of Cardiovascular Disease and Genitourinary Cancer Treatments - Javid Moslehi

March 16, 2020

Details